Read the Final Materials

Final Recommendation Statement, Evidence Reviews, and Decision Modeling Reports

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

The following documents can be accessed by visiting the Task Force’s Web site. Drafts of these documents were posted for public comment from April 21 to May 18, 2015.

Final Recommendation Statement
Clinical Summary
Final Evidence Review: Screening for Breast Cancer
Final Evidence Review: Supplemental Screening in Women With Dense Breasts
Final Evidence Review: Screening With Digital Breast Tomosynthesis
Modeling Report: Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening
Modeling Report: Collaborative Modeling of U.S. Breast Cancer Screening Strategies

*Task Force Recommendation Grades. Grades A and B, recommended. Grade C, recommendation depends on individual patient. Grade D, not recommended. Grade I, not enough evidence.


After an in-depth review of the strongest available science on the benefits and harms of screening mammography, as well as input from the public and health care professionals during the public comment period, the Task Force issued its final recommendations on breast cancer screening on January 12, 2016. You can learn more about how the Task Force’s final recommendations converge with other evidence-based guidelines in an editorial published in Annals of Internal Medicine.


This site does not belong to U.S Preventive Services Task Force (USPSTF)